1. Home
  2. CPHC vs TIL Comparison

CPHC vs TIL Comparison

Compare CPHC & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canterbury Park Holding Corporation 'New'

CPHC

Canterbury Park Holding Corporation 'New'

HOLD

Current Price

$15.62

Market Cap

83.3M

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$8.81

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPHC
TIL
Founded
1994
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
74.7M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
CPHC
TIL
Price
$15.62
$8.81
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
1.4K
57.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.81%
N/A
EPS Growth
N/A
52.54
EPS
N/A
N/A
Revenue
$59,227,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.14
N/A
52 Week Low
$14.49
$5.67
52 Week High
$21.61
$42.75

Technical Indicators

Market Signals
Indicator
CPHC
TIL
Relative Strength Index (RSI) 51.19 53.12
Support Level $15.06 $6.85
Resistance Level $16.02 $9.81
Average True Range (ATR) 0.29 0.66
MACD -0.02 0.05
Stochastic Oscillator 64.02 50.58

Price Performance

Historical Comparison
CPHC
TIL

About CPHC Canterbury Park Holding Corporation 'New'

Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: